Thymus teaches immune cells to ignore vital gut bacteria

April 29, 2013, Medical College of Georgia
This image shows Anna Cebula (from left), Dr. Leszek Ignatowicz and Dr. Richard A. McIndoe, Medical College of Georgia at Georgia Regents University. Credit: Phil Jones

The tiny thymus teaches the immune system to ignore the teeming, foreign bacteria in the gut that helps you digest and absorb food, researchers say.

When recognize essential bacteria as foreign, inflammatory bowel disease such as and Crohn's disease can be the painful, debilitating result.

In a study published in the journal Nature, researchers show that the , or Tregs, that keep this from happening in most of us come from the tiny immune organ nestled near the heart, said Dr. Leszek Ignatowicz, in the Center for Biotechnology and Genomic Medicine at the Medical College of Georgia at Georgia Regents University.

In fact, mice born lacking T that were given a specific T cell type that causes colitis-like wasting disease, didn't get the disease if they also received thymus-derived Tregs.

"This essential gut-bacteria is one group that you don't want to mount an against," said Ignatowicz, the study's corresponding author. "In fact, you need the Tregs' help in inducing tolerance to these bacteria if you want to treat Crohn's and other inflammatory bowel disease."

Knowing exactly where the Tregs come from is essential to making more of them, noted Dr. Richard A. McIndoe, the center's Associate Director and a study co-author. "The Tregs have to shut down the immune response. The question is: Do we have to expand the pre-existing Tregs that came to the gut from the thymus or teach peripheral naïve or effector T cells to become Tregs? "

The answer was thought to be that most immune cells learn to ignore the vital bacteria after they reach the gut. However, the new study shows that only a fraction of bacteria-friendly Tregs come from there. Since T cells don't have , they looked at their antigen receptors and found the Tregs in the gut had the same receptors as their precursors in the thymus. Easing the comparison was the fact that naïve T cells, which also get their education in the thymus, have mostly different receptors than thymus-educated Tregs.

They soon realized that while conversion of naïve cells to Tregs occurs more often in the gut than other organs, it was much less frequent than conventionally believed. Once in the gut, naïve cells can become Tregs or effector cells; effector cells only attack unless constrained by Tregs.

"We either have to induce effector T cells to change to Tregs or boost the number of Tregs coming out of the thymus to help patients with ," McIndoe said. Some compounds, including vitamin A and transforming growth factor beta, already are known to aid conversion.

While T-cells mostly earn their receptors in the thymus, most don't take action until they actually see their chosen antigens, a variety of substances that can provoke an immune response. Well-educated thymus-derived Tregs can recognize antigens from the body's tissue as well as foreign antigens derived from sources like gut bacteria. Interestingly most immune cells circulating in the body are naïve T-cells that become effector cells upon their first contact with an antigen.

It was previously believed that -derived Tregs primarily protect the body's own tissue but don't induce tolerance to foreign antigens like ones derived from gut's bacteria. However Ignatowicz and Dr. Rafal Pacholczyk reported in 2007 in the journal Immunity that Tregs could actually recognize both self- and non-self-antigens. The gut, which regularly deals with an onslaught of foreign substances such as food and drink, was a logical place to figure out where the accommodating Tregs originated, Ignatowicz said.

MCG scientists note that effector cells also are needed in the gut to recognize and eliminate harmful bacteria, such as campylobacter, a common cause of diarrhea, vomiting and abdominal cramping that can result from eating inadequately washed and cooked poultry.

Populating starts early, with mother's milk or formula, and is determined largely by diet as well as the environment so every individual's is different although bacteria tend to be compatible among the same species, McIndoe said.

Vaccines are likely the oldest example of using the body's natural defense system to protect against invaders. Conversely, select immune cell populations already are being used to help fight cancer. More sophisticated approaches are being developed to turn down the immune response, in the case of an organ transplant or an autoimmune disease such as lupus or arthritis.

Explore further: Researchers find regulatory T-cell clue to help prevent GVHD

Related Stories

Researchers find regulatory T-cell clue to help prevent GVHD

October 31, 2011
Graft-versus-host disease (GVHD) is a serious risk in many kinds of cell transplants, including for stem cell transplants carried out when stem cells are partially depleted of conventional T cells, which play an important ...

Self-regulation of the immune system suppresses defense against cancer

December 21, 2011
Regulatory T cells, which are part of the body's immune system, downregulate the activity of other immune cells, thus preventing the development of autoimmune diseases or allergies. Scientists at the German Cancer Research ...

Re-educating immune system: New cell therapy prevents organ rejection

May 18, 2011
Researchers at King's College London have used cells found naturally in the body, to re-educate the immune system to prevent rejection of an organ transplant while remaining capable of fighting infections and cancer.

Recommended for you

Improving vaccines for the elderly by blocking inflammation

January 22, 2018
By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.